fig1

Figure 1. Tumor heterogeneity and drug resistance. Primary tumors are heterogeneous. Subpopulations of cancer cells showing partial or full resistance to therapy are present. The activation of resistance mechanisms can be due to the activation of genetic or epigenetic mechanisms that could be caused by the therapy itself and by the interaction of tumor cells with the microenvironment. This figure is generated with Biorender.com.